Analyst Salim Syed works at MIZUHO and is focused on the Healthcare sector with 267 price targets and ratings documented since 2016 spanning on 13 stocks. Analyst's average stock valuation to be materialised ratio is 49.33% with an average time for price targets to be met of 171.08 days.
Most recent stock forecast was given on ASMB, Assembly Biosciences, Inc at 16-Nov-2022.
Salim Syed best performing recommendations are on UBX (UNITY BIOTECHNOLOGY, INC).
The best stock recommendation documented was for UBX (UNITY BIOTECHNOLOGY, INC) at 8/16/2022. The price target of $8 was fulfilled within 2 days with a profit of $5.7 (41.61%) receiving and performance score of 208.03.
Average potential price target upside
